Consolidated Statements of Income (Unaudited) (USD $) In Millions, except Per Share data	3 Months Ended		9 Months Ended
	Sep. 30, 2011	Sep. 30, 2010	Sep. 30, 2011	Sep. 30, 2010
Revenues
Premiums and fees	$ 4,748	$ 4,621	$ 14,267	$ 13,668
Net investment income	297	280	860	829
Mail order pharmacy revenues	368	354	1,056	1,053
Other revenues	187	(17)	296	230
Realized investment gains (losses):
Other-than-temporary impairments on debt securities, net	(23)	0	(25)	(1)
Other realized investment gains	36	28	81	45
Total realized investment gains before income taxes	13	28	56	44
Total revenues	5,613	5,266	16,535	15,824
Benefits and Expenses
Health Care medical claims expense	2,014	2,148	6,125	6,435
Other benefit expenses	1,272	892	3,324	2,748
Mail order pharmacy cost of goods sold	309	291	874	866
GMIB fair value loss	224	22	245	182
Other operating expenses	1,497	1,449	4,454	4,268
Total benefits and expenses	5,316	4,802	15,022	14,499
Income before Income Taxes	297	464	1,513	1,325
Income taxes:
Current	114	101	274	256
Deferred	(17)	55	201	182
Total taxes	97	156	475	438
Net Income	200	308	1,038	887
Less: Net Income Attributable to Noncontrolling Interest	0	1	1	3
Shareholders' net income	$ 200	$ 307	$ 1,037	$ 884
Shareholders' net income	$ 0.74	$ 1.13	$ 3.85	$ 3.23
Diluted Earnings Per Share:
Shareholders' net income	$ 0.74	$ 1.13	$ 3.80	$ 3.20
Dividends Declared Per Share	$ 0	$ 0	$ 0.040	$ 0.040